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A recent meta-analysis by Passos et al.1 investigated the relationship between inflammatory 
markers and post-traumatic stress disorder (PTSD). This paper is a valuable resource, and 
likely to remain so, since effect estimates were obtained in several cases by contacts with 
original authors, when they could not be estimated directly from published papers. However, 
the question of bias could have been more thoroughly addressed and we suspect that 
effects may have been overestimated. Here, we present additional investigations of bias, 
focussing on IL-6, since this outcome had the greatest number of studies investigated (k = 
15).  
 
Data from Passos et al. were re-coded by one investigator (GN). Following Passos et al., we 
performed a meta-analysis using R2 with the metafor package3. All data and code are openly 
available at dx.doi.org/10.5281/zenodo.44726. Reanalysis produced a standardised mean 
difference summary estimate of 0·88 [95% CI 0·40, 1·35], p = 0·0003, replicating the original 
results. A funnel plot revealed considerable heterogeneity and a skewed distribution (figure 
1).  One study (Guo et al. 2012) appeared to be an outlier. Exclusion of this outlier reduced 
the overall effect estimate to 0·66 [0·35, 0·97], and Egger’s test was significant among the 
remaining non-outlier studies, b = 3·31, z = 2·34, p = 0·019. As one possible adjustment for 
bias, we performed a cumulative meta-analysis with studies sorted by precision. The four 
largest studies gave an aggregate estimate of 0·33 [0·14, 0.53] (figure 1).  
   
Figure 1. Left: Funnel plot. Right: Cumulative meta-analysis with studies sorted by 
precision. 
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Passos et al. addressed heterogeneity by meta-regression on depression and medication 
status. Meta-regression on either of these variables resolved some heterogeneity, but these 
predictors were highly correlated. Sample size is another possible moderator, reflecting 
small-study effects. We suspect that small-study effects may contribute to an overestimation 
of the association between PTSD and IL-6, but because sample size was highly correlated 
with depression and medication status, it is hard to tell which of medication, comorbid MDD, 
or research bias truly predicts observed effect size.  
 
Aside from small-study effects, we are also concerned about the risk of confounding, as the 
meta-analysis concerns observational associations. Of particular concern is possible 
confounding by pretraumatic vulnerability or by burden of somatic diseases associated with 
elevated inflammatory markers. Whereas Passos et al. propose that trauma induces chronic 
low-grade inflammation, an alternative and testable explanation is that this apparent 
association may instead be due to one or more unobserved additional variables. 
 
In conclusion, our results suggest that the association between PTSD status and circulating 
IL-6 may have been overestimated by Passos et al, and that it is difficult to disentangle the 
effects of medication, comorbid MDD, and possible research bias in the available data. We 
recommend that clinical implications be treated with caution. While the putative connection 
between immune activation and PTSD is very interesting, the observational data analysed 
here are not evidence for causal mechanisms, and, in our view, do not yet warrant clinical 
trials of anti-IL-6 agents against PTSD. 
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